DENVER, Colo., Sept 8, 2023 (www.247marketnews.com)- This morning’s 15 minutes after the opening bell snap shot.
Biocept, Inc. (BIOC:NASDAQ) signed a non-exclusive licensing agreement for CNSide with Plus Therapeutics, Inc. (PSTV:NASDAQ), expanding the two companies’ June 2022 comprehensive laboratory services agreement.
Biocept is trading at hit a high of $1.85 and is trading at $1.49, up $0.65 (+77.77%), on 47.72M shares traded.
Plus Therapeutics is trading at $2.89, down $0.08 (-2.69%), on 2.63M shares traded.
Smartsheet Inc. (SMAR:NASDAQ) is higher, after its CEO announced that “Smartsheet outperformed across all aspects of our guidance in Q2,” at $44.50, up $4.14 (+10.26%), on 2.28M shares.
AGBA Group Holding Limited (AGBA:NASDAQ ) announced a new up to US$50 million equity facility and is trading at $0.78, up $0.07 (+9.32%), on 9.19M shares.
Smith & Wesson (SWBI:NASDAQ) is trading at $12.47, up $1.96 (+18.65%), on 1.23M shares.
Cymabay Therapeutics (CBAY:NASDAQ) is adding to yesterday’s gains and is at $16.29, up $1.28 (+8.53%), on 746.74K shares.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.